- Home
- NBIX vs RTO Comparison
NBIX vs RTO Comparison
Compare NBIX & RTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- RTO
- Stock Information
- Founded
- NBIX 1992
- RTO 1925
- Country
- NBIX United States
- RTO United Kingdom
- Employees
- NBIX N/A
- RTO N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- RTO Business Services
- Sector
- NBIX Health Care
- RTO Consumer Discretionary
- Exchange
- NBIX Nasdaq
- RTO Nasdaq
- Market Cap
- NBIX 11.0B
- RTO 12.2B
- IPO Year
- NBIX 1996
- RTO N/A
- Fundamental
- Price
- NBIX $87.58
- RTO $19.89
- Analyst Decision
- NBIX Buy
- RTO Hold
- Analyst Count
- NBIX 21
- RTO 1
- Target Price
- NBIX $164.80
- RTO N/A
- AVG Volume (30 Days)
- NBIX 1.3M
- RTO 1.0M
- Earning Date
- NBIX 04-30-2025
- RTO 03-26-2025
- Dividend Yield
- NBIX N/A
- RTO 2.96%
- EPS Growth
- NBIX 33.20
- RTO N/A
- EPS
- NBIX 3.29
- RTO 0.15
- Revenue
- NBIX $2,355,300,000.00
- RTO $6,805,463,398.00
- Revenue This Year
- NBIX $15.48
- RTO $6.81
- Revenue Next Year
- NBIX $16.18
- RTO $3.82
- P/E Ratio
- NBIX $26.38
- RTO $26.74
- Revenue Growth
- NBIX 24.81
- RTO 1.14
- 52 Week Low
- NBIX $86.58
- RTO $19.60
- 52 Week High
- NBIX $157.98
- RTO $34.07
- Technical
- Relative Strength Index (RSI)
- NBIX 20.83
- RTO 26.58
- Support Level
- NBIX $113.05
- RTO $19.60
- Resistance Level
- NBIX $112.74
- RTO $23.32
- Average True Range (ATR)
- NBIX 3.20
- RTO 0.60
- MACD
- NBIX -1.46
- RTO -0.20
- Stochastic Oscillator
- NBIX 4.59
- RTO 7.59
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About RTO Rentokil Initial plc
Rentokil Initial is the largest global provider of route-based pest-control and commercial hygiene services, operating in 83 countries. The group also offers a range of specialist route-based services including office and commercial space plant care, property care, and workwear rentals. The group has a diverse client base that includes global food producers, hotel chains, industrial goods businesses, restaurants, and individual residential customers.